Ignite Creation Date:
2024-05-06 @ 8:17 AM
Last Modification Date:
2024-10-26 @ 11:58 AM
Study NCT ID:
NCT02703272
Status:
TERMINATED
Last Update Posted:
2022-12-02
First Post:
2016-03-03
Brief Title:
A Safety and Efficacy Study of Ibrutinib in Pediatric and Young Adult Participants With Relapsed or Refractory Mature B-cell Non-Hodgkin Lymphoma
Sponsor:
Janssen Research Development LLC
Organization:
Janssen Research Development LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-07-01
Start Date Type:
ACTUAL
Primary Completion Date:
2021-06-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-06-11
Completion Date Type:
ACTUAL
First Submit Date:
2016-03-03
First Submit QC Date:
March 3 2016
Study First Post Date:
2016-03-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2022-12-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-11-07
Last Update Post Date:
2022-12-02
Last Update Post Date Type:
ACTUAL